Universidad de Salamanca
Salamanca, 37007, Spain
NCT Number: NCT04670315
Stroke is one of the most prevalent pathologies worldwide and its consequences require long-term treatment. The current situation caused by the Sars-cov-2 virus has collapsed health systems and has delayed these patient's treatment. The proposed alternative is telerehabilitation: a treatment system that has already proved its effectiveness. However, the difficulty to assess the stroke patient's functional status is the great problem. For this reason, a Fugl Meyer Assessment Scale adaptation, one of the most widely used (in research and in clinic), is proposed to be carried out remotely. The objective of our study is to validate this scale in stroke patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Salamanca, 37007, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Validation of the Telematic Spanish Version of the Fugl Meyer Assessment Scale
Time frame: baseline
Time frame: Baseline
Time frame: Baseline
Time frame: Baseline
University of Salamanca
Other
Validation of theTelematic Spanish Version of the Fugl-Meyer Assessment of Motor Recovery After Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07404631
Brain Diseases, Cardiovascular Diseases
Cairo, Egypt
View Trial DetailsNCT07502326
Brain Diseases, Cardiovascular Diseases
Seoul, South Korea
View Trial DetailsNCT07768683
Brain Diseases, Cardiovascular Diseases
Costa Masnaga, Italy
View Trial DetailsNCT07504692
Brain Diseases, Cardiovascular Diseases
Bosisio Parini, Lecco, Italy
View Trial Details